This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Apr 14;6(5):489-90.

doi: 10.1021/acsmedchemlett.5b00148. eCollection 2015 May 14.

Inhibitors of the PD-1/PD-L1 Pathway Can Mobilize the Immune System: An Innovative Potential Therapy for Cancer and Chronic Infections

Ahmed F Abdel-Magid¹

Affiliations

PMID: 26005519
PMCID: PMC4434459
DOI: 10.1021/acsmedchemlett.5b00148

Inhibitors of the PD-1/PD-L1 Pathway Can Mobilize the Immune System: An Innovative Potential Therapy for Cancer and Chronic Infections

Ahmed F Abdel-Magid. ACS Med Chem Lett. 2015.

. 2015 Apr 14;6(5):489-90.

doi: 10.1021/acsmedchemlett.5b00148. eCollection 2015 May 14.

Author

Ahmed F Abdel-Magid¹

Affiliation

¹ Therachem Research Medilab (India) Pvt. Ltd. , Jaipur, India.

PMID: 26005519
PMCID: PMC4434459
DOI: 10.1021/acsmedchemlett.5b00148

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Similar articles

PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules.
Geng Q, Jiao P, Jin P, Su G, Dong J, Yan B. Geng Q, et al. Curr Pharm Des. 2018 Feb 12;23(39):6033-6041. doi: 10.2174/1381612823666171004120152. Curr Pharm Des. 2018. PMID: 28982322 Review.
Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm.
Rao M, Valentini D, Dodoo E, Zumla A, Maeurer M. Rao M, et al. Int J Infect Dis. 2017 Mar;56:221-228. doi: 10.1016/j.ijid.2017.01.028. Epub 2017 Feb 2. Int J Infect Dis. 2017. PMID: 28163164 Review.
Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer Immunotherapy.
Jiao P, Geng Q, Jin P, Su G, Teng H, Dong J, Yan B. Jiao P, et al. Curr Pharm Des. 2018;24(41):4911-4920. doi: 10.2174/1381612824666181112114958. Curr Pharm Des. 2018. PMID: 30417781 Review.
[Recommendation of Diagnosis and Management for the Infections Related to Immune Checkpoint Inhibitors].
Lu M, Zhang L, Li Y, Wang H, Guo X, Zhou J, Duan L, Si X, Xu Y, Zhang L. Lu M, et al. Zhongguo Fei Ai Za Zhi. 2019 Oct 20;22(10):666-670. doi: 10.3779/j.issn.1009-3419.2019.10.11. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31650951 Free PMC article. Review. Chinese.
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L, Liu Y, Wang Y. Xia L, et al. Oncologist. 2019 Feb;24(Suppl 1):S31-S41. doi: 10.1634/theoncologist.2019-IO-S1-s05. Oncologist. 2019. PMID: 30819829 Free PMC article. Review.

See all similar articles

Cited by

The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves.
Kerr WG, Chisholm JD. Kerr WG, et al. J Immunol. 2019 Jan 1;202(1):11-19. doi: 10.4049/jimmunol.1800991. J Immunol. 2019. PMID: 30587569 Free PMC article. Review.
A pH-responsive Pickering Nanoemulsion for specified spatial delivery of Immune Checkpoint Inhibitor and Chemotherapy agent to Tumors.
Jia L, Pang M, Fan M, Tan X, Wang Y, Huang M, Liu Y, Wang Q, Zhu Y, Yang X. Jia L, et al. Theranostics. 2020 Aug 7;10(22):9956-9969. doi: 10.7150/thno.46089. eCollection 2020. Theranostics. 2020. PMID: 32929327 Free PMC article.
Computational Insight Into the Small Molecule Intervening PD-L1 Dimerization and the Potential Structure-Activity Relationship.
Shi D, An X, Bai Q, Bing Z, Zhou S, Liu H, Yao X. Shi D, et al. Front Chem. 2019 Nov 12;7:764. doi: 10.3389/fchem.2019.00764. eCollection 2019. Front Chem. 2019. PMID: 31781546 Free PMC article.
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Xu-Monette ZY, Zhang M, Li J, Young KH. Xu-Monette ZY, et al. Front Immunol. 2017 Dec 4;8:1597. doi: 10.3389/fimmu.2017.01597. eCollection 2017. Front Immunol. 2017. PMID: 29255458 Free PMC article. Review.
In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models.
Ashizawa T, Iizuka A, Kanematsu A, Ando T, Maeda C, Miyata H, Yamashita K, Ikeya T, Kikuchi Y, Maruyama K, Nagashima T, Urakami K, Yamaguchi K, Akiyama Y. Ashizawa T, et al. In Vivo. 2025 Jan-Feb;39(1):80-95. doi: 10.21873/invivo.13805. In Vivo. 2025. PMID: 39740910 Free PMC article.

See all "Cited by" articles

References

1. World J Gastroenterol. 2009 Nov 7;15(41):5129-40 - PubMed
1. Curr Mol Med. 2012 Mar;12(3):259-67 - PubMed
1. Trends Mol Med. 2015 Jan;21(1):24-33 - PubMed
1. Expert Opin Ther Targets. 2015 Feb;19(2):201-11 - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Chemical Information
- BindingDB
Research Materials
- NCI CPTC Antibody Characterization Program